Review Version 1 Preserved in Portico This version is not peer-reviewed
Monkeypox Outbreak in Peru: Reflections after the COVID-19 Pandemic
Version 1 : Received: 7 May 2023 / Approved: 9 May 2023 / Online: 9 May 2023 (04:11:23 CEST)
A peer-reviewed article of this Preprint also exists.
Ramírez-Soto, M.C. Monkeypox Outbreak in Peru. Medicina 2023, 59, 1096. Ramírez-Soto, M.C. Monkeypox Outbreak in Peru. Medicina 2023, 59, 1096.
Monkeypox is a zoonotic illness caused by the Orthopoxvirus monkeypox virus (MPXV). Since 1970, outbreaks of MPXV have occurred in several Sub-Saharan African countries. However, from May 2022 to April 2023, recent outbreaks of MPXV occurred in several countries outside of Africa, and these cases quickly spread to over 100 non-endemic countries on all continents. Because of this, in July 2022, World Health Organization declared monkeypox a Public Health Emergency of International. MPXV disproportionately affects men who have sex with men and members of the HIV-infected population. The current strategy for control and pre-exposure prophylaxis or post-exposure prophylaxis for people at high risk is vaccination. In this context, Peru has the fourth-highest number of MPXV cases in Latin America. Because of this, in this review, we describe public health indicators in Peru and reflect on the COVID-19 pandemic so that health authorities can join forces to identify and control MPXV transmission routes.
Monkeypox outbreak; Public health; emergency; Peru
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.Leave a public comment
Send a private comment to the author(s)